Quipt Home Medical Stock (NASDAQ:QIPT), Trade Ideas

Quipt Home Medical

Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.

Earnings

News

Penny Stocks

Pre-Market Outlook

Markets

Trading Ideas

QIPT

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:

HEICO, EMCOR Group And 3 Stocks To Watch Heading Into Monday

COST

The CNN Money Fear and Greed index showed a decline in overall market sentiment, but the index remained in the &#34;Greed&#34; zone on Friday.

The Dow Jones index closed higher on Friday, with all three major indices recording gains for the seventh straight week.

Investor Sentiment Falls But Fear &amp; Greed Index Remains In &#39;Greed&#39; Zone

Health Care

General

Picture credit: Tim Goedhart on Unsplash

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Respiratory Care Market Poised For Growth?

Quipt Home Medical Corp

The French industrial giant&nbsp;Schneider Electric&nbsp;SE&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/SBGSY#OTC">SBGSY</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SBGSF#OTC">SBGSF</a>) has&nbsp;<a target="_blank" href="https://www.se.com/ww/en/assets/564/document/465961/schneider-electric-press-release-19-04-2024.pdf" rel="noreferrer noopener">confirmed&nbsp;</a>holding discussions for a potential acquisition of&nbsp;Bentley Systems&nbsp;Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSY#NASDAQ">BSY</a>), a company known for its engineering software solutions.&nbsp;
As per the Schneider Electric statement, discussions regarding a potential transaction remain at a preliminary stage, emphasizing the lack of certainty regarding the outcome of these talks.
Bentley Systems also acknowledged the&nbsp;public statement&nbsp;made today by Schneider Electric&nbsp;<a target="_blank" href="https://www.benzinga.com//node/38331965" rel="noreferrer noopener">in response to recent market speculation.</a>
Earlier, The&nbsp;Wall Street Journal&nbsp;<a target="_blank" href="https://www.wsj.com/business/deals/schneider-electric-in-talks-to-take-control-of-bentley-systems-d0aad58f?mod=hp_lista_pos2" rel="noreferrer noopener">reported&nbsp;</a>that Schneider Electric and Bentley Systems are considering merging Schneider&#8217;s software business with Bentley, potentially resulting in a deal exceeding $15 billion.&nbsp;
Despite the potential merger, Bentley&nbsp;is expected&nbsp;to remain a publicly traded entity, albeit significantly&nbsp;larger&nbsp;than before.
Bentley Systems, a family-controlled company co-founded by brothers Keith and Barry Bentley in 1984, specializes in providing software for structural and civil engineers involved in infrastructure projects.
Their software&nbsp;is utilized&nbsp;across various sectors, including transportation, water treatment, and construction.
With an annual revenue surpassing $1 billion, Bentley Systems went public in 2020. The recent leadership transition saw Chief Executive Greg Bentley assuming the role of executive chair of the board of directors, with Nicholas Cumins set to become the<a target="_blank" href="https://www.benzinga.com//node/37867934" rel="noreferrer noopener">&nbsp;new chief executive effective July 1.</a>
According to the report, Schneider Electric, valued at approximately $127 billion, has a history of strategic acquisitions to bolster its industrial software portfolio, aiming to compete with industry giants like&nbsp;Siemens&nbsp;AG&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/SIEGY#OTC">SIEGY</a>) and&nbsp;Rockwell Automation Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>).
The potential acquisition of Bentley Systems follows Schneider&#8217;s earlier move in 2017 when it acquired the British&nbsp;engineering-software&nbsp;provider&nbsp;Aveva Group.
Price Action: BSY, which closed higher by 3.89% at $52.06 on Thursday, is trading lower by 0.12% at $52 premarket Friday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Shutterstock

Equities

Movers

Media

SBGSF

SBGSY

SIEGY

What's Going On With Bentley Systems Stock Amid Multibillion-Dollar Merger Talks?

Tech billionaire and X owner <a href="https://www.benzinga.com/topic/elon-musk">Elon Musk</a> has issued a stern warning to users doing &#8220;engagement farming&#8221; activities on his social media platform.
What Happened: Musk has warned users on X, formerly Twitter, about the consequences of &#8220;engagement farming&#8221; and has threatened to suspend the accounts involved.
"Any accounts doing engagement farming will be suspended and traced to source."
Engagement farming refers to the practice of artificially boosting the engagement metrics of an account, such as likes, retweets, and followers, through the use of automated systems or other means.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/04/38243800/another-setback-for-elon-musk-after-ccdh-lawsuit-thrown-out-media-matters-wins-injunction-against-te" target="_blank" rel="noreferrer noopener">Another Setback For Elon Musk: After CCDH Lawsuit Thrown Out, Media Matters Wins Injunction Against Texas AG's Investigation</a>
On Friday, Musk took to X to address this issue. Accounts found to be artificially boosting engagement metrics could be suspended. A similar policy is also applied on Reddit, where users who engage in vote brigading are suspended.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Musk did not elaborate on the methods that would be used to trace the source of the engagement farming activities.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Any accounts doing engagement farming will be suspended and traced to source
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1781183251731677264?ref_src=twsrc%5Etfw">April 19, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Musk&#8217;s warning comes as a response to the increasing prevalence of fake accounts and automated systems on social media platforms, which are used to artificially inflate the popularity of certain users or content.
On Monday, Musk announced that X will start charging a "small fee" to allow new users to post on the social media platform to <a href="https://www.benzinga.com/news/24/04/38264187/elon-musk-says-charging-new-x-users-a-small-fee-is-the-only-way-to-curb-bot-onslaught">curb the onslaught of bots</a>.
This was after a test that X carried out in New Zealand and the Philippines in November. Musk&#8217;s X&nbsp;<a href="https://www.benzinga.com/news/23/10/35300682/just-joining-elon-musks-x-you-will-now-have-to-shell-out-1-for-proper-access-if-you-live-in-these-tw" target="_blank" rel="noreferrer noopener">introduced a $1 annual subscription fee</a> as part of the "Not A Bot" program to mitigate spam, manipulation, and bot activity.
Check out more of Benzinga's Future Of Consumer Tech by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next: <a href="https://www.benzinga.com/news/24/04/38111017/tesla-ceo-elon-musk-disagrees-with-nvidias-jensen-huang-that-anyone-can-make-their-own-neural-networ?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla CEO Elon Musk Disagrees With Nvidia&#8217;s Jensen Huang That Anyone Can Make Their Own Neural Network</a>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Social Media

Tech

Elon Musk Says Accounts Doing 'Engagement Farming' On X Will Be Suspended

WIIM

LUNA

Luna Innovations shares are trading lower after the company announced the restatement of financial statements due to identified accounting errors relating to revenue recognition.

Jefferies analyst Brent Thill maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Buy and raises the price target from $175 to $180.

Price Target

Analyst Ratings

GOOG

GOOGL

Jefferies Maintains Buy on Alphabet, Raises Price Target to $180

Goldman Sachs analyst George Tong maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Neutral and lowers the price target from $276 to $241.

Goldman Sachs Maintains Neutral on Equifax, Lowers Price Target to $241

Innovative Industrial Properties, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) shares closed slightly <a href="https://www.benzinga.com/real-estate/reit/24/02/37095768/3-high-yield-reits-with-the-best-total-return-over-the-past-three-months">higher during Thursday's session</a>.
On March 15, Innovative Industrial Properties said its board of directors declared a first-quarter 2024 dividend of $1.82 per share of common stock.
The San Diego-based company reported better-than-expected earnings results for its fourth quarter on Feb. 26, 2024. Piper Sandler analyst Alexander Goldfarb maintained Innovative Industrial Properties with a Neutral and raised the price target from $85 to $103 following the release of quarterly earnings.
With the recent buzz around Innovative Industrial Properties, some investors may be eyeing potential gains from the company's dividends. As of now, Innovative Industrial Properties has a dividend yield of 7.75%, which is a quarterly dividend amount of $1.82 a share ($7.28 a year).
To figure out how to earn $500 monthly from Innovative Industrial Properties, we start with the yearly target of $6,000 ($500 x 12 months).
Next, we take this amount and divide it by Innovative Industrial Properties' $7.28 dividend: $6,000 / $7.28 &nbsp;= 824 shares
So, an investor would need to own approximately $77,357 worth of Innovative Industrial Properties, or 824 shares, to generate a monthly dividend income of $500.
Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $7.28 = 165 shares, or $15,490 to generate a monthly dividend income of $100.
Also Read: <a href="https://www.benzinga.com/news/24/04/38289255/crowdstrike-wayfair-and-2-other-stocks-insiders-are-selling">CrowdStrike, Wayfair And 2 Other Stocks In</a><a href="https://www.benzinga.com/news/24/04/38289255/crowdstrike-wayfair-and-2-other-stocks-insiders-are-selling">siders Are Selling</a>
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.
For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).
Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).
Further, the dividend payment itself can also change over time, which can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.
IIPR Price Action: Shares of Innovative Industrial Properties rose 0.3% to close at $93.88 on Thursday.
Read More: <a href="https://www.benzinga.com/news/24/04/38322367/wall-streets-most-accurate-analysts-views-on-3-utilities-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts&#8217; Views On 3 Utilities Stocks Delivering High-Dividend Yields</a>

Long Ideas

IIPR

How To Earn $500 A Month From Innovative Industrial Properties Stock

Jefferies analyst David Windley maintains Elevance Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) with a Buy and raises the price target from $602 to $604.

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

Jefferies Maintains Buy on Elevance Health, Raises Price Target to $604

CLIR

ClearSign Technologies Prices Underwritten 4,620,760 Share Offering At $0.91/Share And $0.01 Per Accompanying Warrant

Barclays analyst Andrew Mok maintains Elevance Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) with a Overweight and raises the price target from $584 to $621.

Barclays Maintains Overweight on Elevance Health, Raises Price Target to $621

NFLX: -7% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/38331078">Netflix shares are trading lower after the company reported Q1 financial results.</a>
CNS: 7% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/38331277">Cohen &amp; Steers shares are trading higher after it was announced the stock will join the S&amp;P SmallCap 600.</a>
RWOD: 217% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/38332302">Redwoods Acquisition shares are trading higher after the company announced that shareholders approved its merger agreement with Anew Medical.</a>

NFLX

RWOD

Market-Moving News for April 19th

Burke &amp; Herbert Annual Shareholder Meeting Date Established
ALEXANDRIA, Va. and MOOREFIELD, W.Va., April 19, 2024 /PRNewswire/ --&nbsp;Burke &amp; Herbert Financial Services Corp. ("Burke &amp; Herbert") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHRB#NASDAQ">BHRB</a>) and Summit Financial Group, Inc. ("Summit") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMF#NASDAQ">SMMF</a>) today announced receipt of all required regulatory approvals or waivers necessary to complete the previously announced merger of equals pursuant to the Agreement and Plan of Reorganization, dated as of August 24, 2023, by and between Burke &amp; Herbert and Summit. The merger is expected to close on May 3, 2024, pending satisfaction of customary closing conditions.
In addition, the Burke &amp; Herbert board of directors has established July 15, 2024, as the date for its annual shareholder meeting for shareholders of record as of May 7, 2024.&nbsp;

BHRB

SMMF

Burke & Herbert Financial Services Corp. And Summit Financial Group, Inc. Announce Receipt Of Regulatory Approvals And Closing Date Of May 3, 2024 For Merger Of Equals

LRHC

La Rosa Regains Nasdaq Compliance

Maxeon Solar Technologies, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAXN#NASDAQ">MAXN</a>), a global leader in solar innovation and channels, today announced that it has initiated a patent infringement lawsuit in the Eastern District of&nbsp;Texas&nbsp;against REC Solar Holdings AS, alleging its infringement of Maxeon patents relating to TOPCon (Tunnel Oxide Passivated Contact) solar cell technology.&nbsp;
Maxeon has a global patent portfolio of over 1,650 granted patents and more than 330 pending patent applications protecting the innovations underpinning its IBC (Interdigitated Back Contact), Shingled Hypercell, and TOPCon technologies.&nbsp;
"Intellectual property infringement sits alongside injurious dumping and subsidy-driven excess global production capacity as an unfair trade practice that distorts markets and tilts what should be a level playing field for global solar manufacturing," said Marc Robinson, Maxeon's Associate General Counsel. "Maxeon strongly supports fair competition and will continue to vigorously enforce the Company's patent rights in the United States and its other markets."&nbsp;

Legal

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

Maxeon Solar Technologies Initiates TOPCon Patent Infringement Lawsuit Against REC Solar Holdings AS

HUBC

HUB Cyber Security Ltd. Addresses Dominion's Lawsuit, Files Counterclaim In New York Court Action, Alleging 'various misconduct by Dominion'

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.lunainc.com&amp;esheet=53939028&amp;newsitemid=20240419143535&amp;lan=en-US&amp;anchor=Luna+Innovations+Incorporated+%28NASDAQ%3A+LUNA%29&amp;index=1&amp;md5=80b7be9be6e1b08f178e2f65bcb269e4">Luna Innovations Incorporated (NASDAQ:</a><a href="https://www.benzinga.com/stock/LUNA#NASDAQ">LUNA</a>) (the "Company"), a global leader in advanced fiber optic-based technology, today announced that its Audit Committee of the Board of Directors (the "Audit Committee"), after consultation with the Company's management and the Special Committee's external legal and financial advisors, determined that its financial statements for the fiscal year ended December 31, 2022, and the interim periods ended March 31, 2022, June 30, 2022, and September 30, 2022 and March 31, 2023, cannot be relied upon and need to be restated due to identified accounting errors relating to revenue recognition. Similarly, any previously issued or filed reports, press releases, earnings releases, investor presentations or other Company communications describing the Company's financial results or other financial information relating to the fiscal year ended December 31, 2022, should no longer be relied upon.
As disclosed on <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.lunainc.com%2Fnews-releases%2Fnews-release-details%2Fluna-innovations-delay-release-fourth-quarter-and-full-year-2023&amp;esheet=53939028&amp;newsitemid=20240419143535&amp;lan=en-US&amp;anchor=March+12&amp;index=2&amp;md5=8568244218fd38dc2fe2a115f7d7d02e">March 12</a>, a Special Committee of the Company's Board of Directors has been conducting an independent review, with the assistance of external legal and financial advisors, of certain revenue recognition matters in connection with the Company's previously issued financial statements.
As the independent review remains ongoing and the full extent of this impact is still being determined, the Company cannot at this time estimate when it will file its restated financial statements. The Company is working diligently on this matter and will provide updated information as appropriate.

Luna Innovations Announces Restatement Of Financial Statements; Says " Determined That Its Financial Statements For The Fiscal Year Ended Dec 31, 2022, Interim Periods Ended Mar 31, 2022, Jun 30, 2022, Sep 30, 2022 And Mar 31, 2023, Cannot Be Relied Upon And Need To Be Restated Due To Identified Accounting Errors Relating To Revenue Recognition"

Equifax Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) reported worse-than-expected first-quarter sales results and issued adjusted guidance <a href="https://www.benzinga.com/quote/EFX/earnings">below estimates on Wednesday</a>.
Equifax posted quarterly sales of $1.389 billion, missing market estimates of $1.400 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Equifax said it sees second-quarter adjusted earnings of $1.65 to $1.75 per share, versus market estimates of $1.87 per share. The company expects revenue of $1.41 billion to $1.43 billion, versus expectations of $1.44 billion.
&#8220;Equifax performed well in the first quarter against our EFX2026 strategic priorities in a very challenging mortgage market delivering revenue of $1.389 billion, up a strong 7%. Our U.S. mortgage business grew a strong 6% despite a 19% decline in USIS mortgage credit inquiries. Our non-mortgage business, which was about 80% of Equifax revenue in the first quarter, delivered very strong broad-based 9% local currency revenue growth, from continued strong new product performance with a New Product Vitality Index of 9% and 85% of new models and scores built using AI and ML. Workforce Solutions delivered very strong 15% non-mortgage Verification Services revenue growth led by the Government business, with 1% overall growth from the U.S. mortgage market decline,&#8221; said Mark W. Begor, Equifax Chief Executive Officer.
Equifax shares fell 8.5% to close at $217.51 on Thursday.
These analysts made changes to their price targets on Equifax following earnings announcement.
<ul>
<li>Baird cut the price target on Equifax from $275 to $260. Baird analyst Jeffrey Meuler maintained an Outperform rating.</li>
<li>JP Morgan lowered the price target on Equifax from $290 to $273. JP Morgan analyst Andrew Steinerman maintained an Overweight rating.</li>
</ul>
Read More: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/04/38331943/insiders-buying-lovesac-company-and-3-other-stocks">Insiders Buying Lovesac Company And 3 Other Stocks</a>

Equifax Analysts Cut Their Forecasts After Q1 Results

CRMD

CorMedix Inc. Announces CMS Grants Transitional Drug Add-On Payment To DefenCath

Barclays analyst Matthew Bouley maintains D.R. Horton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) with a Overweight and lowers the price target from $186 to $176.

Barclays Maintains Overweight on D.R. Horton, Lowers Price Target to $176

Craig-Hallum analyst Ryan Sigdahl upgrades Rush Street Interactive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSI#NYSE">RSI</a>) from Hold to Buy and raises the price target from $7 to $8.

Upgrades

Craig-Hallum Upgrades Rush Street Interactive to Buy, Raises Price Target to $8

Regions Financial shares are trading lower after the company reported mixed Q1 financial results.

Quipt Home Medical Corp. (QIPT) Q4 2023 Earnings Call Transcript

Quipt Home Medical files for C$300M mixed securities shelf

6 Top Long-Term Stocks On My 2024 Wishlist

Notable earnings after Wednesday's close

Quipt Home Medical GAAP EPS of -$0.01 beats by $0.01, revenue of $65.4M beats by $1.1M

Quipt Home Medical Corp. (QIPT) Q1 2024 Earnings Call Transcript

Quipt Home Medical Corp (TSE:QIPT) has released an update. Quipt Home Medical Corp., a provider of in-home respiratory care and chronic disease man...

Quipt Home Medical to Attend Roth Investor Conference

Quipt Home Medical Stock: Strong Demand For Respiratory Care Can Lift Shares Higher

Quipt Home Medical Corp (TSE:QIPT) has released an update. Quipt Home Medical Corp. reported successful voting outcomes from its annual shareholder...

Quipt Home Medical Shareholders Meeting Success

Quipt Home Medical Corp (TSE:QIPT) has released an update. Quipt Home Medical Corp. has successfully conducted its annual general and special meeti...

Quipt Home Medical Reports Key Meeting Outcomes

ABNB

ACGL

ADPT

AEMD

AMWL

ATUS

AYTU

BKNG

BLDR

CNVS

CRWD

CSCO

ELTP

EPRT

EQIX

EXPE

FBRT

FCPT

FROG

FSLY

GPMT

HUBS

MMLP

NMIH

NRDS

NTST

NVDA

PATH

PEGA

PGRE

PLTR

PTEN

RBBN

RGLD

ROIC

TRIP

TWLO

UDMY

UPWK

VECO

Press Releases

Quipt Home Medical Announces Date and Time for Fiscal Q3 2023 Conference Call and Audio Webcast

Quipt Home Medical Reports Strong Operational Performance With Record Third Quarter Fiscal 2023 Financial Results Posting Revenue Growth of 64% and Adjusted EBITDA Growth of 80%

Quipt Announces Multi-State Acquisition Adding Approximately $9 Million in Annualized Revenues, and Anticipated $2 Million in Adjusted EBITDA Post Integration

Quipt Home Medical Corp. to Announce Fourth Quarter and Full Year 2023 Financial Results on December 18, 2023

Quipt Home Medical Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results Posting Revenue Growth of 59% and Adjusted EBITDA Growth of 73%

Quipt Home Medical Corp. Announces Filing of Preliminary Base Shelf Prospectus to Replace Recently Expired Base Shelf Prospectus

Quipt Home Medical Corp. to Announce Fiscal First Quarter 2024 Financial Results on February 14, 2024

Quipt Home Medical Reports Strong Operating Performance With Record First Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 60% and Adjusted EBITDA Growth of 71%

Quipt Home Medical Announces Participation in the 36th Annual Roth Investor Conference on March 17-19, 2024

Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders

TSX:QIPT

Raymond James

Benchmark

Canaccord Genuity